Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentnuclear matrix

KRT18 TENM1 PRKCD HNRNPU DNMT3A

2.39e-04140835GO:0016363
GeneOntologyCellularComponentchromosomal region

NCAPD3 ATR BRCA2 ALYREF HNRNPU KNL1 DNMT3A SEPTIN2

2.67e-04421838GO:0098687
GeneOntologyCellularComponentperinuclear region of cytoplasm

SNF8 KRT18 UACA ANKRD13C MYO5B OSBPL6 TENM1 PRKCD TAOK1 ROS1 PLCG2 SEPTIN2

3.07e-049348312GO:0048471
GeneOntologyCellularComponentcytoplasmic region

EFHC2 DNAH3 MYO5B GRIK2 HNRNPU CFAP46 SEPTIN2

5.73e-04360837GO:0099568
GeneOntologyCellularComponentnuclear periphery

KRT18 TENM1 PRKCD HNRNPU DNMT3A

5.99e-04171835GO:0034399
GeneOntologyCellularComponentsex chromosome

ATR HNRNPU DNMT3A

7.11e-0444833GO:0000803
GeneOntologyCellularComponentruffle membrane

CDC37 EPB41L5 MACF1 PLCG2

9.05e-04108834GO:0032587
GeneOntologyCellularComponentcuticular plate

SPTAN1 PVALB

1.18e-0313832GO:0032437
GeneOntologyCellularComponentruffle

CDC37 VIL1 EPB41L5 MACF1 PLCG2

1.38e-03206835GO:0001726
GeneOntologyCellularComponentleading edge membrane

CDC37 EPB41L5 MACF1 PLCG2 USH2A

1.50e-03210835GO:0031256
GeneOntologyCellularComponentcell projection membrane

CDC37 SLC6A19 EPB41L5 MACF1 PLCG2 USH2A SEPTIN2

1.63e-03431837GO:0031253
GeneOntologyCellularComponentplasma membrane bounded cell projection cytoplasm

EFHC2 DNAH3 GRIK2 HNRNPU CFAP46 SEPTIN2

1.65e-03317836GO:0032838
GeneOntologyCellularComponentspliceosomal complex

DHX15 SF3B3 PTBP2 ALYREF HNRNPU

1.66e-03215835GO:0005681
DomainSpectrin

TRIO SPTAN1 MACF1

1.21e-0423793PF00435
DomainSpectrin_repeat

TRIO SPTAN1 MACF1

2.46e-0429793IPR002017
DomainSpectrin/alpha-actinin

TRIO SPTAN1 MACF1

3.31e-0432793IPR018159
DomainSPEC

TRIO SPTAN1 MACF1

3.31e-0432793SM00150
DomainAlbA_2

SLFN5 SLFN14

3.66e-047792PF04326
DomainSchlafen

SLFN5 SLFN14

3.66e-047792IPR029684
DomainSchlafen_AAA_dom

SLFN5 SLFN14

3.66e-047792IPR007421
DomainKinase-like_dom

ATR TRIO MACF1 PRKCD TAOK1 ROS1 RIPK4 MAP4K4

2.05e-03542798IPR011009
DomainSH3

ARHGEF19 TRIO SPTAN1 MACF1 PLCG2

2.22e-03216795PS50002
DomainSH3_domain

ARHGEF19 TRIO SPTAN1 MACF1 PLCG2

2.41e-03220795IPR001452
DomainAnk

ANKRD31 ANKS6 UACA ANKRD13C RIPK4

2.81e-03228795PF00023
DomainEF-hand_1

EFHC2 SPTAN1 PVALB MACF1

3.95e-03152794PF00036
DomainANK

ANKRD31 ANKS6 UACA ANKRD13C RIPK4

4.23e-03251795SM00248
DomainANK_REPEAT

ANKRD31 ANKS6 UACA ANKRD13C RIPK4

4.38e-03253795PS50088
DomainANK_REP_REGION

ANKRD31 ANKS6 UACA ANKRD13C RIPK4

4.45e-03254795PS50297
DomainAnkyrin_rpt

ANKRD31 ANKS6 UACA ANKRD13C RIPK4

5.07e-03262795IPR002110
DomainC2_dom

OSBPL6 PRKCD PLCG2 PTEN

5.17e-03164794IPR000008
DomainSH3_1

ARHGEF19 TRIO SPTAN1 PLCG2

5.17e-03164794PF00018
DomainEF-hand_7

SPTAN1 PVALB MACF1

5.61e-0385793PF13499
DomainEF-hand-dom_pair

EFHC2 SPTAN1 PVALB MACF1 PLCG2

7.39e-03287795IPR011992
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

DHX15 CDC37 SF3B3 KRT18 MICAL2 FDPS SPTAN1 INTS11 SUPT16H EPB41L5 MACF1 PRKCD ALYREF PLCG2 EXOC2 CBR1 DIS3 HNRNPU

2.53e-091353831829467282
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

DHX15 CDC37 NCAPD3 EMC3 SF3B3 KRT18 UACA FDPS SPTAN1 SUPT16H ALYREF MRPL45 EXOC2 DENND1A DIS3 HNRNPU SLC27A2 IWS1

6.66e-091440831830833792
Pubmed

Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.

DHX15 CCDC91 NCAPD3 SF3B3 SUPT16H FBRS MAP4K4 DIS3

1.36e-0818283832239614
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

DHX15 EMC3 SF3B3 OFD1 KRT18 MYO5B SUPT5H SUPT16H MACF1 ALYREF MAP4K4 CBR1 HNRNPU FAM83B ABCB1

1.84e-081024831524711643
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

DHX15 CDC37 NCAPD3 SF3B3 ATR TRIO SUPT5H SPTAN1 INTS11 SUPT16H PRKCD ALYREF MAP4K4 CBR1 DIS3 HNRNPU SEPTIN2

3.70e-081425831730948266
Pubmed

Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis.

DHX15 SF3B3 PTBP2 SUPT5H SPTAN1 SUPT16H

3.70e-0711683637117180
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

EMC3 OFD1 KRT18 TRIO MYO5B SUPT5H SPTAN1 INTS11 SUPT16H PTEN CNTROB KNL1 IWS1

1.19e-061049831327880917
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

DHX15 CDC37 SF3B3 KRT18 UACA MYO5B SYNM SPTAN1 SUPT16H ALYREF RSBN1L HNRNPU FAM83B SEPTIN2

1.56e-061257831436526897
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

DHX15 SNF8 CDC37 STRN3 RAP1GDS1 KRT18 SUPT5H FDPS SPTAN1 SUPT16H MACF1 DIS3 HNRNPU IWS1 SEPTIN2

1.64e-061455831522863883
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

DHX15 SF3B3 PTBP2 SUPT5H SPTAN1 INTS11 SUPT16H MACF1 MRPL45 MAP4K4 HNRNPU DNMT3A IWS1

1.68e-061082831338697112
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

RAP1GDS1 TRIO SYNM SUPT5H MICAL2 SPTAN1 OLFM1 MACF1 TAOK1 RIPK4 MAP4K4 CBR1 RSBN1L SEPTIN2

2.01e-061285831435914814
Pubmed

Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.

DHX15 CDC37 SPTAN1 ALYREF MAP4K4 HNRNPU

2.10e-0615683622952844
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

EFHC2 TBC1D32 ANKS6 SF3B3 OFD1 MYO5B SUPT5H SUPT16H FBRS OSBPL6 ALYREF EXOC2 DENND1A DIS3

2.77e-061321831427173435
Pubmed

A protein interaction landscape of breast cancer.

CDC37 BRCA2 TRIO MYO5B SUPT5H MICAL2 SUPT16H MACF1 CBR1 FAM83B

2.78e-06634831034591612
Pubmed

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

DHX15 SF3B3 SYNM PTBP2 SUPT5H ALYREF DIS3 HNRNPU IWS1 SEPTIN2

3.61e-06653831033742100
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

DHX15 KRT18 UACA SUPT5H SPTAN1 SUPT16H MACF1 ALYREF IWS1 SEPTIN2

3.96e-06660831032780723
Pubmed

Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.

DHX15 CDC37 RAP1GDS1 SF3B3 KRT18 SUPT5H SUPT16H ALYREF CBR1 DIS3 HNRNPU KNL1 IWS1 SEPTIN2

4.11e-061367831432687490
Pubmed

Pot1a prevents telomere dysfunction and ATM-dependent neuronal loss.

ATR BRCA2 PVALB

4.68e-061483324899707
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

SNF8 VIL1 RAP1GDS1 UACA MYO5B SLC6A19 PRKCD ALYREF TAOK1 CBR1 SLC27A2 ABCB1

5.21e-061016831219056867
Pubmed

Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages.

PRKCD RIPK4

5.63e-06283218511573
Pubmed

Depletion of DNMT3A suppressed cell proliferation and restored PTEN in hepatocellular carcinoma cell.

PTEN DNMT3A

5.63e-06283220467490
Pubmed

Abrogation of ATR function preferentially augments cisplatin-induced cytotoxicity in PTEN-deficient breast cancer cells.

ATR PTEN

5.63e-06283237802411
Pubmed

Management of atypical pneumonias in view of the new entity "Legionnaire's disease".

KRT18 USH2A

5.63e-062832276901
Pubmed

FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.

FDPS PTEN

5.63e-06283230914801
Pubmed

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.

ATR PTEN

5.63e-06283229396668
Pubmed

DIK, a novel protein kinase that interacts with protein kinase Cdelta. Cloning, characterization, and gene analysis.

PRKCD RIPK4

5.63e-06283210948194
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

VIL1 STRN3 SF3B3 KRT18 MYO5B PTBP2 SPTAN1 SUPT16H TENM1 MACF1 C2orf78 HNRNPU CFAP46 ABCB1

7.56e-061442831435575683
Pubmed

BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.

DHX15 VIL1 SPTAN1 SUPT16H MACF1 ALYREF CBR1 HNRNPU SLC27A2 SEPTIN2

7.60e-06711831033022573
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

DHX15 CDC37 SF3B3 KRT18 UACA MYO5B MICAL2 FDPS SPTAN1 ALYREF DIS3 HNRNPU FAM83B

7.82e-061247831327684187
Pubmed

HENA, heterogeneous network-based data set for Alzheimer's disease.

UACA TRIO SPTAN1 OLFM1 MACF1

1.05e-0512083531413325
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

SF3B3 ATR PTBP2 SPTAN1 MACF1 TAOK1 EXOC2 HNRNPU KNL1

1.06e-0558283920467437
Pubmed

Functional specialization of beta-arrestin interactions revealed by proteomic analysis.

DHX15 DNAH3 SF3B3 ATR SPTAN1 ALYREF HNRNPU

1.12e-0531783717620599
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

DHX15 NCAPD3 SF3B3 ATR KRT18 SUPT5H INTS11 SUPT16H ALYREF SLFN5 HNRNPU SLC27A2 IWS1

1.16e-051294831330804502
Pubmed

Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system.

DHX15 STRN3 PTBP2 HNRNPU

1.33e-056083429055695
Pubmed

The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.

OFD1 KRT18 UACA MYO5B SPTAN1 ALYREF HNRNPU

1.40e-0532883723398456
Pubmed

Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.

SF3B3 KRT18 SUPT5H SPTAN1 EXOC2 IWS1

1.47e-0521983631353912
Pubmed

SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.

DHX15 SF3B3 KRT18 PTBP2 SPTAN1 ALYREF CBR1 HNRNPU

1.53e-0546383834901782
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

STRN3 NCAPD3 ATR UACA SPTAN1 PRKCD TAOK1 EXOC2 MAP4K4 IWS1

1.58e-05774831015302935
Pubmed

DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.

DHX15 SPTAN1 SUPT16H HNRNPU

1.61e-056383437052853
Pubmed

Centrobin: a novel daughter centriole-associated protein that is required for centriole duplication.

BRCA2 CNTROB

1.69e-05383216275750
Pubmed

ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.

ATR PTEN

1.69e-05383228273450
Pubmed

Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families.

BRCA2 PTEN

1.69e-05383217636424
Pubmed

Epoxygenase Cyp2c44 Regulates Hepatic Lipid Metabolism and Insulin Signaling by Controlling FATP2 Localization and Activation of the DAG/PKCδ Axis.

PRKCD SLC27A2

1.69e-05383238743615
Pubmed

Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathways.

ATR BRCA2

1.69e-05383224672057
Pubmed

FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells.

PRKCD ABCB1

1.69e-05383224814288
Pubmed

Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth.

BRCA2 PTEN

1.69e-05383225176644
Pubmed

A high-resolution genetic map around waltzer on mouse chromosome 10 and identification of a new allele of waltzer.

ROS1 GRIK2

1.69e-0538329021139
Pubmed

ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy.

PTEN ABCB1

1.69e-05383224647572
Pubmed

Conditional Pten knockout in parvalbumin- or somatostatin-positive neurons sufficiently leads to autism-related behavioral phenotypes.

PVALB PTEN

1.69e-05383233504340
Pubmed

Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment.

BRCA2 PTEN

1.69e-05383231940494
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

DHX15 CDC37 STRN3 SF3B3 KRT18 SPTAN1 SUPT16H MACF1 ALYREF CBR1 HNRNPU SEPTIN2

1.78e-051149831235446349
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

STRN3 UACA TRIO SPTAN1 SUPT16H MACF1 ALYREF GRIK2 MAP4K4 HNRNPU SEPTIN2

1.82e-05963831128671696
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SAMD9L LRRN1 UACA MYO5B SYNM EPB41L5 MACF1 TAOK1

2.40e-0549383815368895
Pubmed

The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.

DHX15 CDC37 SF3B3 SPTAN1 ALYREF HNRNPU

2.40e-0523983626641092
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

DHX15 CDC37 SF3B3 KRT18 SPTAN1 SUPT16H HNRNPU SEPTIN2

2.43e-0549483826831064
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

DHX15 EMC3 SF3B3 KRT18 SPTAN1 SUPT16H MACF1 ALYREF EXOC2 CBR1 DIS3 HNRNPU IWS1

2.96e-051415831328515276
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

DHX15 STRN3 RAP1GDS1 SF3B3 TRIO MYO5B MICAL2 SPTAN1 OSBPL6 MACF1 CBR1 HNRNPU SEPTIN2

3.32e-051431831337142655
Pubmed

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.

PTEN ABCB1

3.37e-05483220056007
Pubmed

Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population.

ATR BRCA2

3.37e-05483220513533
Pubmed

Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.

BRCA2 PTEN

3.37e-05483224615332
Pubmed

Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy.

PLA2G7 ABCB1

3.37e-05483227641736
Pubmed

Nutritional modulation of mouse and human liver bud growth through a branched-chain amino acid metabolism.

KRT18 BCAT2

3.37e-05483228219950
Pubmed

Disruption of spectrin-like cytoskeleton in differentiating keratinocytes by PKCδ activation is associated with phosphorylated adducin.

SPTAN1 PRKCD

3.37e-05483222163289
Pubmed

Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.

BRCA2 PTEN

3.37e-05483231806642
Pubmed

Pten and EphB4 regulate the establishment of perisomatic inhibition in mouse visual cortex.

PVALB PTEN

3.37e-05483227611660
Pubmed

ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.

ATR BRCA2

3.37e-05483223548269
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

OFD1 KRT18 TRIO SPTAN1 OSBPL6 EPB41L5 MACF1 MAP4K4 DENND1A FAM83B

3.91e-05861831036931259
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

SYNM TENM1 EPB41L5 MACF1 MAP4K4 FAM83B

4.10e-0526383634702444
Pubmed

Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer.

ALYREF MAP4K4 IWS1

4.11e-052883324462114
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

CDC37 EMC3 SF3B3 OFD1 UACA SYNM SPTAN1 SUPT16H EPB41L5 MACF1 MRPL45 MAP4K4 FAM83B

4.93e-051487831333957083
Pubmed

The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus.

DHX15 SF3B3 SPTAN1 ALYREF HNRNPU

5.46e-0516983523084401
Pubmed

Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.

ATR BRCA2

5.60e-05583218642075
Pubmed

A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells.

PTEN DNMT3A

5.60e-05583223435381
Pubmed

Keratin impact on PKCδ- and ASMase-mediated regulation of hepatocyte lipid raft size - implication for FasR-associated apoptosis.

KRT18 PRKCD

5.60e-05583227422101
Pubmed

Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice.

PTEN DNMT3A

5.60e-05583220889571
Pubmed

Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts.

PRKCD PLCG2

5.60e-05583222806935
Pubmed

Iws1 and Spt6 Regulate Trimethylation of Histone H3 on Lysine 36 through Akt Signaling and are Essential for Mouse Embryonic Genome Activation.

ALYREF IWS1

5.60e-05583230846735
Pubmed

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

BRCA2 PTEN

5.60e-05583224332043
Pubmed

FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH.

SUPT5H SUPT16H

5.60e-05583210912001
Pubmed

Cdx2 regulates endo-lysosomal function and epithelial cell polarity.

VIL1 MYO5B SPTAN1

6.79e-053383320551175
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

SF3B3 BRCA2 SUPT5H FBRS MACF1 DIS3 KNL1 FAM83B

8.25e-0558883838580884
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

STRN3 EMC3 TRIO FDPS SPTAN1 TENM1 OLFM1 MACF1 PTEN MAP4K4 HNRNPU

8.28e-051139831136417873
Pubmed

Early-Life Gene Expression in Neurons Modulates Lasting Epigenetic States.

PVALB DNMT3A

8.39e-05683229056337
Pubmed

High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.

BRCA2 PTEN

8.39e-05683228608929
Pubmed

Schlafen, a new family of growth regulatory genes that affect thymocyte development.

SLFN5 SLFN14

8.39e-0568329846487
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

DHX15 SF3B3 BRCA2 KRT18 PTBP2 SUPT16H ALYREF RSBN1L HNRNPU KNL1

9.16e-05954831036373674
Pubmed

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.

SF3B3 UACA SUPT16H MACF1 ALYREF TAOK1 MAP4K4 DIS3

9.60e-0560183833658012
Pubmed

ZNF212 promotes genomic integrity through direct interaction with TRAIP.

CDC37 KRT18 CNTROB

9.60e-053783336594163
Pubmed

Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.

KRT18 UACA SPTAN1 MACF1 SEPTIN2

9.73e-0519183533762435
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

STRN3 OFD1 SPTAN1 MAP4K4 CNTROB DENND1A FAM83B

9.76e-0544683724255178
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

DHX15 VIL1 UACA SPTAN1 INTS11 SUPT16H EPB41L5 ALYREF TAOK1 ROS1 DENND1A RSBN1L

9.78e-051371831236244648
Pubmed

The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation.

DHX15 SF3B3 SPTAN1 SUPT16H EPB41L5 ALYREF HNRNPU ABCB1

9.93e-0560483837616343
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

DHX15 SF3B3 KRT18 SUPT5H SUPT16H ALYREF HNRNPU IWS1

1.00e-0460583828977666
Pubmed

Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

UACA EPB41L5 DENND1A KNL1

1.03e-0410183410997877
Pubmed

Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

TRIO GRIK2 SERPINA2 USH2A

1.03e-0410183418519826
Pubmed

Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly.

CDC37 STRN3 OFD1

1.04e-043883336674791
Pubmed

CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.

NCAPD3 UACA EPB41L5 EXOC2

1.16e-0410483431240132
Pubmed

The Calcium Channel Subunit Alpha2delta2 Suppresses Axon Regeneration in the Adult CNS.

PVALB TENM1

1.17e-04783227720483
Pubmed

Parvalbumin interneuron activity in autism underlies susceptibility to PTSD-like memory formation.

PVALB PTEN

1.17e-04783238741709
Pubmed

The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export.

ALYREF IWS1

1.17e-04783217234882
InteractionBRCA1 interactions

DHX15 CDC37 NCAPD3 SF3B3 ATR BRCA2 KRT18 TRIO SUPT5H MICAL2 SPTAN1 SUPT16H ALYREF USH2A MAP4K4 CBR1 HNRNPU KNL1 SEPTIN2

5.61e-0712498319int:BRCA1
InteractionKDF1 interactions

DHX15 CCDC91 NCAPD3 SF3B3 SUPT16H FBRS MAP4K4 DIS3

1.26e-06192838int:KDF1
InteractionECT2 interactions

DHX15 CCDC91 SF3B3 OFD1 MYO5B SPTAN1 SUPT16H EPB41L5 MACF1 ALYREF RIPK4 MRPL45 HNRNPU FAM83B SEPTIN2

2.96e-068878315int:ECT2
InteractionRHOB interactions

RAP1GDS1 UACA TRIO SPTAN1 SUPT16H OSBPL6 EPB41L5 MACF1 PRKCD EXOC2 MAP4K4 HNRNPU FAM83B SEPTIN2

7.81e-068408314int:RHOB
InteractionPLEC interactions

NCAPD3 DNAH3 ATR BRCA2 KRT18 SPTAN1 MACF1 CASQ2 PTEN DIS3

1.07e-054308310int:PLEC
InteractionEED interactions

DHX15 NCAPD3 SF3B3 KRT18 TRIO MYO5B SUPT5H SPTAN1 SUPT16H MACF1 ALYREF EXOC2 PSPH PTEN CBR1 DIS3 HNRNPU DNMT3A

1.91e-0514458318int:EED
InteractionRHOF interactions

NCAPD3 RAP1GDS1 EMC3 ATR UACA SPTAN1 SUPT16H EPB41L5 MACF1 MAP4K4 DIS3 FAM83B

1.93e-056738312int:RHOF
InteractionNELFE interactions

DHX15 SF3B3 PTBP2 SUPT5H SPTAN1 SUPT16H DIS3

1.93e-05201837int:NELFE
InteractionGSK3A interactions

DHX15 CDC37 SF3B3 OFD1 TRIO PTBP2 MACF1 PRKCD CNTROB HNRNPU

2.06e-054648310int:GSK3A
InteractionCDCA5 interactions

DHX15 CDC37 ARHGEF19 SF3B3 MYO5B SPTAN1

2.46e-05140836int:CDCA5
InteractionNEDD1 interactions

SF3B3 OFD1 CILP ALYREF PTEN CNTROB HNRNPU

3.55e-05221837int:NEDD1
InteractionCDC5L interactions

DHX15 SF3B3 ATR KRT18 TRIO PTBP2 SUPT5H SPTAN1 MACF1 ALYREF EXOC2 HNRNPU KNL1

4.45e-058558313int:CDC5L
InteractionKRT18 interactions

DHX15 OFD1 KRT18 FDPS USH2A CNTROB HNRNPU CFAP46 FAM83B

5.63e-05419839int:KRT18
InteractionYWHAB interactions

DHX15 CDC37 NCAPD3 KRT18 UACA SPTAN1 OSBPL6 EPB41L5 MACF1 PRKCD TAOK1 RIPK4 DENND1A FAM83B

6.27e-0510148314int:YWHAB
InteractionDISC1 interactions

CDC37 OFD1 TRIO SYNM SPTAN1 OLFM1 MACF1 ALYREF MAP4K4

6.74e-05429839int:DISC1
InteractionCOPE interactions

EFHC2 CDC37 EMC3 SF3B3 MICAL2 SPTAN1 ROS1 SEPTIN2

7.01e-05334838int:COPE
InteractionCDKN2A interactions

EFHC2 CDC37 RAP1GDS1 ATR SUPT16H EXOC2 PTEN HNRNPU

7.16e-05335838int:CDKN2A
InteractionSNRPC interactions

SF3B3 OFD1 SUPT5H INTS11 SUPT16H MACF1 ALYREF HNRNPU IWS1

8.18e-05440839int:SNRPC
InteractionCDK2 interactions

DHX15 CDC37 RAP1GDS1 SF3B3 OFD1 ATR BRCA2 SPTAN1 SUPT16H ALYREF CNTROB HNRNPU

8.36e-057838312int:CDK2
InteractionPPP2R1A interactions

DHX15 CDC37 STRN3 NCAPD3 KRT18 SYNM SUPT5H FDPS INTS11 RIPK4 MAP4K4

8.67e-056658311int:PPP2R1A
InteractionEPYC interactions

EPYC PLCG2

1.00e-044832int:EPYC
InteractionDIRAS3 interactions

CDC37 RAP1GDS1 SPTAN1 EPB41L5 MACF1 MAP4K4 FAM83B

1.04e-04262837int:DIRAS3
InteractionGRK5 interactions

DHX15 CDC37 SPTAN1 ALYREF MAP4K4 HNRNPU

1.06e-04182836int:GRK5
InteractionIWS1 interactions

DHX15 SUPT5H SUPT16H ALYREF IWS1

1.18e-04116835int:IWS1
InteractionH2BC21 interactions

DHX15 SUPT5H INTS11 SUPT16H OSBPL6 TENM1 CASQ2 MAP4K4 HNRNPU CFAP46 IWS1

1.30e-046968311int:H2BC21
InteractionPPP5C interactions

CDC37 RAP1GDS1 ATR RIPK4 PTEN DIS3 HNRNPU

1.31e-04272837int:PPP5C
InteractionYWHAH interactions

CDC37 OFD1 KRT18 UACA TRIO SPTAN1 OSBPL6 EPB41L5 MACF1 TAOK1 RIPK4 MAP4K4 DENND1A FAM83B

1.51e-0411028314int:YWHAH
InteractionYWHAG interactions

DHX15 CDC37 SF3B3 KRT18 UACA SPTAN1 OSBPL6 EPB41L5 MACF1 PRKCD TAOK1 RIPK4 MAP4K4 DENND1A FAM83B

1.57e-0412488315int:YWHAG
InteractionSNRPA interactions

DHX15 SF3B3 PTBP2 SUPT5H SUPT16H ALYREF PTEN HNRNPU IWS1

1.63e-04482839int:SNRPA
InteractionPPP2CA interactions

STRN3 NCAPD3 BRCA2 SUPT5H INTS11 EPB41L5 PRKCD PTEN MAP4K4

1.68e-04484839int:PPP2CA
InteractionCUL7 interactions

DHX15 CDC37 SF3B3 KRT18 SUPT5H SUPT16H MACF1 CASQ2 ALYREF CBR1 HNRNPU ABCB1

1.71e-048458312int:CUL7
InteractionSOX2 interactions

DHX15 PTBP2 SUPT5H SPTAN1 INTS11 SUPT16H FBRS MACF1 PRKCD ALYREF SLFN5 PSPH CBR1 HNRNPU KNL1 SEPTIN2

1.97e-0414228316int:SOX2
InteractionUHRF1 interactions

TBC1D32 ATR SUPT16H ALYREF HNRNPU DNMT3A

2.19e-04208836int:UHRF1
InteractionACIN1 interactions

DHX15 BRCA2 SUPT5H SUPT16H ALYREF IWS1 SEPTIN2

2.43e-04301837int:ACIN1
InteractionEFTUD2 interactions

DHX15 SNF8 EMC3 SF3B3 KRT18 SUPT5H SPTAN1 SUPT16H MACF1 ALYREF EXOC2 PTEN CBR1 DIS3 HNRNPU IWS1

2.44e-0414498316int:EFTUD2
InteractionPLK1 interactions

NCAPD3 SF3B3 OFD1 BRCA2 INTS11 OSBPL6 PTEN CNTROB HNRNPU

2.48e-04510839int:PLK1
InteractionTRIM37 interactions

SF3B3 OFD1 KRT18 SYNM SPTAN1 MAGEB18 ALYREF PTEN CNTROB HNRNPU

2.59e-046308310int:TRIM37
InteractionCMTR1 interactions

DHX15 SF3B3 SUPT5H EPB41L5 ALYREF HNRNPU

2.82e-04218836int:CMTR1
InteractionEPB41L4A interactions

SPTAN1 EPB41L5 MACF1 MAP4K4 FAM83B

2.83e-04140835int:EPB41L4A
InteractionKIF23 interactions

DHX15 SF3B3 MYO5B MICAL2 SPTAN1 SUPT16H MACF1 ALYREF PTEN MAP4K4 HNRNPU SLC27A2 FAM83B

2.88e-0410318313int:KIF23
InteractionC11orf52 interactions

UACA TRIO SPTAN1 EPB41L5 MACF1 MAP4K4 FAM83B

2.97e-04311837int:C11orf52
InteractionEXOC1 interactions

STRN3 TRIO SPTAN1 MACF1 EXOC2

3.12e-04143835int:EXOC1
InteractionBIRC3 interactions

DHX15 CDC37 SF3B3 ATR TRIO SUPT5H SPTAN1 SUPT16H PRKCD ALYREF RIPK4 CBR1 DIS3 HNRNPU SEPTIN2

3.24e-0413348315int:BIRC3
InteractionNAA16 interactions

ALYREF RIPK4 HNRNPU

3.36e-0433833int:NAA16
InteractionEME2 interactions

BRCA2 PTEN

3.47e-047832int:EME2
InteractionKIF20A interactions

DHX15 SAMD9L SF3B3 UACA PTBP2 SPTAN1 SUPT16H MACF1 ALYREF PLCG2 MAP4K4 HNRNPU FAM83B

3.50e-0410528313int:KIF20A
InteractionPOLR2A interactions

BRCA2 SUPT5H INTS11 SUPT16H ALYREF PTEN HNRNPU DNMT3A IWS1

3.57e-04536839int:POLR2A
InteractionHDGF interactions

DHX15 KRT18 SUPT16H ALYREF RIPK4 PTEN HNRNPU

3.59e-04321837int:HDGF
InteractionSLMAP interactions

STRN3 OFD1 MAP4K4 CNTROB FAM83B

3.77e-04149835int:SLMAP
InteractionHSPA4 interactions

CDC37 OFD1 ATR BRCA2 KRT18 TRIO PRKCD RIPK4 PTEN KNL1

4.07e-046678310int:HSPA4
InteractionAKT3 interactions

CDC37 PRKCD MAP4K4 IWS1

4.20e-0485834int:AKT3
InteractionTPBG interactions

SF3B3 HNRNPU SEPTIN2

4.36e-0436833int:TPBG
GeneFamilySchlafen family

SLFN5 SLFN14

2.25e-0476021110
GeneFamilyAnkyrin repeat domain containing

ANKRD31 ANKS6 UACA ANKRD13C RIPK4

1.24e-03242605403
CoexpressionAtlasDevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000

NCAPD3 KRT18 TRIO MYO5B TENM1 EPB41L5 ROS1 GRIK2 RIPK4 PSPH PTEN SLC27A2 DNMT3A

1.14e-058018213gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5

BRCA2 MYO5B SUPT16H EPB41L5 TAOK1 HNRNPU IWS1

1.41e-05204827Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

BRCA2 ANKRD13C MYO5B PTBP2 SPTAN1 SUPT16H EPB41L5 TAOK1 HNRNPU IWS1

3.80e-055328210Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3

BRCA2 PTBP2 SUPT16H HNRNPU KNL1 IWS1

1.00e-04192826Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500

LRRN1 BRCA2 PTBP2 SUPT16H EPB41L5 GRIK2 HNRNPU KNL1 IWS1

1.28e-04498829Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlasdev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500

OFD1 ATR BRCA2 SLC27A2

1.39e-0468824gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4

LRRN1 PTBP2 SUPT16H EPB41L5 TAOK1 HNRNPU IWS1

1.55e-04298827Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlasDevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_500

MYO5B TENM1 EPB41L5 ROS1 GRIK2 PSPH SLC27A2 DNMT3A

1.59e-04401828gudmap_developingKidney_e11.5_ureteric bud_500
CoexpressionAtlasdev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_1000

OFD1 ATR BRCA2 SLC27A2

1.74e-0472824gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_1000
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class

SAMD9L SPTAN1 TENM1 MACF1 SLFN5 SLC27A2

1.97e-06199836f307d4887b28cf60a591439e278fd668409cb104
ToppCellmetastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass

DNAH3 CILP EPYC ROS1 GRIK2

1.17e-05158835ab05f6d7968ccd6d3826cd71b763dbedc83822c3
ToppCell5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIL1 KRT18 MYO5B RIPK4 SLC27A2

1.86e-05174835e7cca4b6a3935fad61cf2a3d9984ab1ffa1a9447
ToppCell5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIL1 KRT18 MYO5B RIPK4 SLC27A2

1.86e-05174835ad5b56f0ace6455c033834b931ec870cc0dc9290
ToppCellfacs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PLA2G7 LRRN1 KRT18 CASQ2 SLC27A2

2.69e-05188835340f0e3e65c7a00d82d26621ff37107458bebc41
ToppCellfacs-Trachea-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PLA2G7 LRRN1 KRT18 CASQ2 SLC27A2

2.69e-051888359d384c0934f1461bc37b1f83e0877d7bee2116ee
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EFHC2 DNAH3 OSBPL6 SLC27A2 CFAP46

3.05e-05193835e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCellPCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

ARHGEF19 KRT18 MYO5B RIPK4 SLC27A2

3.05e-05193835979980369d2dbee9dc4770d72b93037abd7786eb
ToppCell10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue

RAP1GDS1 OFD1 MICAL2 PLCG2 ABCB1

3.13e-051948355c58a2d1dd3c8ff77ce44d473239685e6b020909
ToppCellPCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

KRT18 MYO5B MICAL2 ROS1 RIPK4

3.13e-05194835c47fc3f716ab091a39c20d7639ac783029589ee5
ToppCell(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)

DHX15 KRT18 SYNM BCAT2 CASQ2

3.29e-05196835541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH3 KRT18 MYO5B SPTAN1 CBR1

3.37e-051978355c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCellfacs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DHX15 TAOK1 RIPK4 MAP4K4 FAM83B

3.45e-051988352f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCellfacs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DHX15 TAOK1 RIPK4 MAP4K4 FAM83B

3.45e-05198835f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCellBAL-Severe|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PLA2G7 SAMD9L MACF1 TAOK1 SLFN5

3.45e-05198835454aee3f4fe6d0beeccc55200b4495f4f9b44feb
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

CCDC91 UACA MRPL45 SLFN5 SLC27A2

3.53e-0519983561b1ed2db71b96157b92b7535d1955a4033098da
ToppCellfacs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DHX15 SF3B3 TAOK1 MAP4K4 HNRNPU

3.53e-051998358d50e1ee58710d896c0204937331d9f4dcd38de0
ToppCellSepsis-Leuk-UTI-Lymphocyte-T/NK-Treg|Leuk-UTI / Disease, condition lineage and cell class

ANKRD31 SPTAN1 OSBPL6 SLFN5 FAM118A

3.53e-05199835100f45e04f284551b29ef0406476bdc347ddbf7e
ToppCell3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIL1 KRT18 SLC6A19 CBR1 ABCB1

3.53e-051998350181c13379f869be47804cdb11bbdabcd30b9b23
ToppCellCOVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class

LRRN1 BRCA2 PLCG2 SLC27A2 KNL1

3.53e-05199835f82fa9d651e78f9ebbe6264e00a48c54b1786a69
ToppCellCOVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class

LRRN1 BRCA2 PLCG2 SLC27A2 KNL1

3.53e-0519983542ea0c19c455bdb0ae89b428d09c333104c670dc
ToppCell3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIL1 KRT18 SLC6A19 CBR1 ABCB1

3.53e-05199835ee981046217e8759610eb58a670d98f32cd83abc
ToppCellControl_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type

NCAPD3 BRCA2 OLFM1 CNTROB KNL1

3.62e-052008359bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SAMD9L MACF1 PLCG2 SLFN5 HNRNPU

3.62e-0520083512f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

EFHC2 DNAH3 OSBPL6 SLC27A2 CFAP46

3.62e-05200835ddd39b754bfaa98249d497dfb7e97ec58617a11a
ToppCellCOVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass

NCAPD3 BRCA2 SUPT16H SLC27A2 KNL1

3.62e-052008357e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCellParenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

EFHC2 DNAH3 OSBPL6 SLC27A2 CFAP46

3.62e-05200835a521cf837cadf280505ff9d7e641a205af7d6513
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

EFHC2 DNAH3 OSBPL6 SLC27A2 CFAP46

3.62e-05200835918b576fd9491d23c2bb9d663fa5fb3505cb1c7e
ToppCellCOVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass

NCAPD3 BRCA2 SUPT16H SLC27A2 KNL1

3.62e-052008359775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Car3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SAMD9L SYNM PRKCD ROS1

1.15e-041348344ef5f395e321cf04e56560be2502a8aa157682f4
ToppCellLeuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type

ANKRD31 SPTAN1 OSBPL6 SLFN5

1.92e-04153834b24c693b142206d13b29c96faa7f79a1a22bc2ef
ToppCelldroplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLA2G7 PRKCD PLCG2 SLFN5

2.56e-04165834e32697321cef424c2ad4e11ee9da3e510d5ce505
ToppCelldroplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLA2G7 PRKCD PLCG2 SLFN5

2.56e-041658340fbdd043e11aa8dbff4cd3a4da1b2feb49878a09
ToppCell5'-Adult-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANKS6 KRT18 FDPS PRKCD

2.62e-041668340b4e1d879c61be9d18d7aac51e5115f103f51209
ToppCellControl|World / group, cell type (main and fine annotations)

MYO5B MICAL2 EPB41L5 ROS1

2.74e-04168834a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLA2G7 PRKCD PLCG2 SLFN5

3.00e-04172834b26fc612f232e8e273825ac2d2e5519cbb7322cf
ToppCellwk_20-22-Hematologic-Meg-ery-Definitive_erythrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

EMC3 MICAL2 SLC6A19 SLFN14

3.00e-04172834f0b658baa4b41329c95a09387cc55ea046e2333f
ToppCellcontrol-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

HTR2B SPTAN1 SLFN5 SLFN14

3.06e-041738340c9fb18536ddd61b51b7bb4d40841f67b017f360
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT18 PVALB TENM1 RSBN1L

3.20e-0417583465571d775d26a40e979dbf290a8e4320c0d9fb3f
ToppCellfacs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PLA2G7 LRRN1 KRT18 SLC27A2

3.41e-041788343d120458a0a56097532ebfa5fc6f77b52af2af2a
ToppCellGlobus_pallidus-Macroglia|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

ARHGEF19 EMC3 PSPH MAP4K4

3.48e-04179834ab50f711b004b96107f813c9a2526ec21d1c8027
ToppCellCOVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations)

KRT18 MYO5B MICAL2 EPB41L5

3.48e-04179834a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCellCOVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYO5B TENM1 SLC27A2 ABCB1

3.56e-04180834358923e4228035a3e90e2957392089219e90dcd7
ToppCelldroplet-Marrow-BM-1m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UACA PRKCD PLCG2 SLFN5

3.63e-0418183489c551de26de047c316c91ac1d97bdf728a33d9e
ToppCellCOVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC6A19 TENM1 SLC27A2 ABCB1

3.63e-041818346980ea624151da32b7f537f263e40fcb87a02e81
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NCAPD3 BRCA2 GRIK2 KNL1

3.71e-04182834336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SAMD9L UACA MAGEB18 ABCB1

3.79e-041838346cdadb3ece45a94a2915063aa461048e1d371ccd
ToppCellCOVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type

KRT18 MYO5B MICAL2 EPB41L5

3.79e-041838347b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CCDC91 UACA EPB41L5 GRIK2

3.79e-041838343c516fe5083f02bad1f464ed284010b4131a833c
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

SAMD9L TRIO TAOK1 SLFN5

3.79e-041838348f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CCDC91 UACA EPB41L5 GRIK2

3.79e-041838349c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo|bone_marrow / Manually curated celltypes from each tissue

OFD1 SYNM FAM118A ABCB1

3.79e-041838342fb78622adc170dd3301e251418337523de50faf
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SAMD9L UACA MAGEB18 ABCB1

3.79e-041838348714d3e7663c93cdf9b25b647353572e136f30c3
ToppCellfacs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT18 OSBPL6 RIPK4 FAM83B

3.79e-04183834ecac1cfaff7553a60305b34d6cede6973ffb5430
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SAMD9L UACA MAGEB18 ABCB1

3.79e-04183834c7fc96ac1d5d31ccefe0c1fc6ec76c7d8607a172
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|bone_marrow / Manually curated celltypes from each tissue

OFD1 SYNM FAM118A ABCB1

3.79e-0418383437db007cc65005bffc18a5fda7f454a57c9fb0a9
ToppCellfacs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT18 OSBPL6 RIPK4 FAM83B

3.79e-04183834f6ebfd7f61e912f92bd07313cc213a171747ac03
ToppCell(7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

KRT18 BCAT2 RIPK4 FAM83B

3.87e-041848341f76b37c265b519171b767a52d48f31f0cdc4a3c
ToppCellE12.5-Epithelial-airway_epithelial_cell-club_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ARHGEF19 KRT18 MICAL2 RIPK4

3.87e-04184834a69c3c57cd939b2888f548a0fbca3392ad310445
ToppCellE12.5-Epithelial-airway_epithelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ARHGEF19 KRT18 MICAL2 RIPK4

3.87e-041848343df78b17098b50e1a7f2c8791bf2d0806328330a
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAP1GDS1 MYO5B MICAL2 ROS1

3.87e-04184834ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CCDC91 UACA EPB41L5 GRIK2

3.87e-041848347294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CCDC91 UACA EPB41L5 GRIK2

3.95e-04185834b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NCAPD3 BRCA2 SLC27A2 KNL1

3.95e-041858349d424a8608b339dd6129c58d87626678d4ec4af7
ToppCellControl-Epithelial-Club|World / Disease state, Lineage and Cell class

KRT18 MYO5B EPB41L5 ROS1

4.03e-041868349798428691408e17ff2af2fe2d1b345f074d67e4
ToppCellPCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

MYO5B MICAL2 ROS1 SLC27A2

4.03e-04186834bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCellCOPD-Epithelial-Club|World / Disease state, Lineage and Cell class

KRT18 MYO5B EPB41L5 ROS1

4.03e-041868343006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCellPCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

LRRN1 KRT18 MYO5B RIPK4

4.11e-04187834c2940aec30b3c2c113f6a65126dc6f1969cf301e
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SAMD9L UACA SLFN5 ABCB1

4.11e-04187834f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCellIPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class

LRRN1 KRT18 MYO5B ROS1

4.11e-0418783419d6a404fc3651d98a93e3848e372df51a239c57
ToppCellfacs-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L MACF1 PRKCD PLCG2

4.11e-041878343ca3954f45f167e98a230f2847f0582d74fcd32e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NCAPD3 BRCA2 GRIK2 KNL1

4.11e-04187834057569c9437219ecc396aa6e673b1178a2273837
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIL1 KRT18 MYO5B SLC27A2

4.19e-04188834d00f48afed62fc60d3530bb3b80ac0162b0b0ed8
ToppCellfacs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VIL1 ANKRD13C SLC6A19 SLC27A2

4.19e-04188834b483b4629695764568bcbd1d527d614824147783
ToppCellCOVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations)

MYO5B MICAL2 EPB41L5 ROS1

4.19e-04188834c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

RAP1GDS1 KRT18 MYO5B MICAL2

4.19e-0418883443a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCellfacs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VIL1 ANKRD13C SLC6A19 SLC27A2

4.19e-04188834c1f64311ff05093b2f4f672e33f5f75e3bc8a8db
ToppCellControl-Epithelial_cells|Control / group, cell type (main and fine annotations)

MYO5B MICAL2 EPB41L5 ROS1

4.19e-04188834707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPTAN1 TENM1 SLFN5 FAM118A

4.28e-041898349ab77c6fcb573854da5922412f53d2168bda6b58
ToppCellPCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

ARHGEF19 MYO5B RIPK4 SLC27A2

4.28e-041898345d9da836ce4308b8458bb3be3871a0aca734b6cd
ToppCellPND10-Epithelial-Epithelial_Airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 KRT18 OSBPL6 CFAP46

4.28e-04189834407d8a59969d83f014600aae1a55092283a13970
ToppCellIPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class

LRRN1 KRT18 MYO5B ROS1

4.28e-041898348030a353473da34ae92429f2d822171a2e94248f
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPTAN1 TENM1 SLFN5 FAM118A

4.28e-041898345a9e2ca9a9ee2dc37ab9147a902115a9f1a80169
ToppCell(2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)

SAMD9L OLFM1 MACF1 ABCB1

4.28e-04189834fa72e87e1e8cd7cbddae7b47e19cf90d181820a7
ToppCellControl-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NCAPD3 BRCA2 OLFM1 KNL1

4.28e-041898341e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell(2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)

SAMD9L OLFM1 MACF1 ABCB1

4.28e-04189834b37ad24898a14a4a3b2d6cea2637de2471f76e20
ToppCellPBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters

NCAPD3 BRCA2 SUPT16H KNL1

4.36e-0419083484ee185939bdefb10705b621a70da27701eadcee
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

KRT18 MYO5B MICAL2 EPB41L5

4.36e-0419083430b50d183d7649146eb1e79b47ba897355f1998a
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPTAN1 MACF1 MAP4K4 HNRNPU

4.36e-04190834d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellwk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

ARHGEF19 LRRN1 KRT18 ALYREF

4.36e-041908349f5f65869dad9a43ac94f81f9a19c72ffe5adc3c
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

EFHC2 MACF1 SLFN5 ABCB1

4.45e-04191834f1935e8f8467a2bc30588b7f2cc3b94e9c83b268
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

EFHC2 MACF1 SLFN5 ABCB1

4.45e-041918341161e465c50c2071764279e01cf08b1048cce0e3
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KRT18 MYO5B OSBPL6 EPB41L5

4.45e-04191834ce76b156b153a2c7c9f2fb8e563b69c81073fbe5
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KRT18 MYO5B OSBPL6 EPB41L5

4.45e-04191834c006f5a6e3a32b79ac99a78304bdd5116fc0d5e0
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

EFHC2 MACF1 SLFN5 ABCB1

4.45e-041918347a4fe96989f72159385270c712342ba3e1ca6fc3
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

BRCA2 PSPH KNL1 SEPTIN2

4.45e-04191834588015d76b68488da6aa6603777682f3d81592bf
ToppCellControl-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class

EFHC2 MACF1 SLFN5 ABCB1

4.45e-04191834e842f29bc03ed6734b2a7b975e7830a498f2743c
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

EFHC2 MACF1 SLFN5 ABCB1

4.45e-04191834c023ca893ceae19b54967096f6e2588dc39fa268
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SYNM SPTAN1 TENM1 SLC27A2

4.45e-041918344a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6
ToppCell(210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization)

SAMD9L MACF1 SLFN5 ABCB1

4.54e-0419283408dc0c019c594da7b9944db8fd706aa7780e6ae9
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

TRIO MACF1 MAP4K4 HNRNPU

1.19e-0450554GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
ComputationalGenes in the cancer module 417.

PLA2G7 PLCG2 SLC27A2

1.82e-0422553MODULE_417
DiseaseSquamous cell carcinoma of oropharynx

ATR PTEN

4.67e-054832C0280313
Diseaseaspartate aminotransferase to alanine aminotransferase ratio

DHX15 ANKRD31 SF3B3 BCAT2 SERPINA2 ABCB1

5.95e-05239836EFO_0010934
DiseaseNeoplasm of uncertain or unknown behavior of ovary

ATR BRCA2 PTEN

7.44e-0529833C0496920
DiseaseOvarian Carcinoma

ATR BRCA2 PTEN

8.25e-0530833C0029925
DiseaseGlioma

ATR BRCA2 ROS1 PTEN

1.08e-0487834C0017638
Diseaseendometrial cancer (implicated_via_orthology)

ATR PTEN

2.16e-048832DOID:1380 (implicated_via_orthology)
Diseaseserum albumin measurement

ARHGEF19 EPB41L5 MACF1 GRIK2 EXOC2 SERPINA2 RSBN1L SEPTIN2

2.64e-04592838EFO_0004535
DiseaseIntellectual Disability

TRIO SUPT16H MACF1 TAOK1 PTEN HNRNPU DNMT3A

2.69e-04447837C3714756
DiseaseMalignant tumor of prostate

BRCA2 PTEN

2.78e-049832cv:C0376358
DiseaseMalignant neoplasm of kidney

BRCA2 PTEN ABCB1

2.80e-0445833C0740457
Diseasehepatocellular carcinoma (implicated_via_orthology)

KRT18 UACA PTEN

3.60e-0449833DOID:684 (implicated_via_orthology)
Diseaseneuritic plaque measurement

TRIO OSBPL6 EPB41L5 CDYL2 GRIK2 PLCG2

4.60e-04349836EFO_0006798
Diseaseossification of the posterior longitudinal ligament of the spine

CCDC91 DNMT3A

5.07e-0412832EFO_0005895
Diseaseovarian neoplasm

ATR BRCA2 GRIK2 PTEN

5.66e-04134834C0919267
DiseaseMalignant neoplasm of ovary

ATR BRCA2 GRIK2 PTEN

6.15e-04137834C1140680
DiseaseHereditary Breast and Ovarian Cancer Syndrome

BRCA2 PTEN

6.96e-0414832C0677776
DiseaseMalignant neoplasm of liver

KRT18 TRIO MYO5B GRIK2

7.04e-04142834C0345904
DiseaseLiver neoplasms

KRT18 TRIO MYO5B GRIK2

7.04e-04142834C0023903
Diseasehyperinsulinism (biomarker_via_orthology)

PRKCD PTEN

8.02e-0415832DOID:2018 (biomarker_via_orthology)
Diseaseprimary autosomal recessive microcephaly (is_implicated_in)

NCAPD3 KNL1

9.14e-0416832DOID:0070296 (is_implicated_in)
Diseasebreast size

CCDC91 OSBPL6 SERPINA2

9.84e-0469833EFO_0004884
DiseaseNon-Small Cell Lung Carcinoma

ROS1 GRIK2 PTEN ABCB1

9.99e-04156834C0007131
Diseasecolorectal cancer (is_marker_for)

BRCA2 PTEN MAP4K4 HNRNPU

1.02e-03157834DOID:9256 (is_marker_for)
DiseaseMalignant Glioma

BRCA2 ROS1 PTEN

1.03e-0370833C0555198
Diseasemixed gliomas

BRCA2 ROS1 PTEN

1.03e-0370833C0259783
DiseaseInborn Errors of Metabolism

PLA2G7 MYO5B

1.03e-0317832C0025521
DiseaseMalignant neoplasm of endometrium

ATR PTEN

1.16e-0318832C0007103
DiseaseCarcinoma in situ of endometrium

ATR PTEN

1.16e-0318832C0346191
DiseaseAdenocarcinoma of prostate

BRCA2 PTEN

1.44e-0320832C0007112
Diseaseleft atrial function

CILP CASQ2

1.59e-0321832EFO_0004294
DiseaseSeckel syndrome

ATR DNMT3A

1.74e-0322832C0265202
DiseaseAutosomal Recessive Primary Microcephaly

NCAPD3 KNL1

1.74e-0322832C3711387
DiseaseCarcinoma of lung

BRCA2 PTEN

1.90e-0323832C0684249
DiseaseNeoplasm of the genitourinary tract

BRCA2 PTEN

2.07e-0324832cv:C0042065
Diseasebreast cancer (implicated_via_orthology)

ATR BRCA2

2.25e-0325832DOID:1612 (implicated_via_orthology)
DiseaseNeurodevelopmental Disorders

TRIO PTEN HNRNPU

2.32e-0393833C1535926
Diseasenon-alcoholic fatty liver disease (is_marker_for)

PLA2G7 KRT18

2.62e-0327832DOID:0080208 (is_marker_for)
DiseaseMalignant tumor of breast

BRCA2 PTEN

2.62e-0327832cv:C0006142
DiseaseBreast neoplasm

BRCA2 PTEN

2.62e-0327832cv:C1458155
DiseaseSezary Syndrome

PTEN DNMT3A

2.62e-0327832C0036920
DiseaseFamilial cancer of breast

BRCA2 PTEN

2.62e-0327832cv:C0346153

Protein segments in the cluster

PeptideGeneStartEntry
KMIRKGVFKDQHFDQ

PRPF4B

911

Q13523
MAENSKFFKKHGIRN

HTR2B

421

P41595
VFHALGKKIDMKTGF

C2orf78

636

A6NCI8
KQGKDQHFPVFMNEK

DNMT3A

841

Q9Y6K1
IMLGDKEKTFQFLHQ

TBC1D32

1076

Q96NH3
FKHFNKLREFVQMKL

ANKRD13C

476

Q8N6S4
FKHMVIVKAKLGQNF

CFAP46

1151

Q8IYW2
AKKAADEAKMRFAHI

DHX15

606

O43143
NIKRGKHMDFLSDFE

IWS1

516

Q96ST2
SDKENQKGFLMHFLK

OFD1

131

O75665
NHDELMKEKGIYFKL

ABCB1

611

P08183
ELGKFAVFVHAKMAE

ARHGEF19

636

Q8IW93
IDGKEKNMHSARFKN

ANKRD31

441

Q8N7Z5
HKFMAFKSFGELVHK

MAP4K4

1056

O95819
LFMKKNHEEEVKGLQ

KRT18

211

P05783
GDMIKFVIRKDKCHF

MAGEB18

131

Q96M61
LLVHGEAKKMEFLKQ

INTS11

411

Q5TA45
HIKIADFGMCKENIF

PRKCD

486

Q05655
HANAKKILLEMGEFF

FDPS

291

P14324
AKFHGKMEQKFLLVD

FAM83B

221

Q5T0W9
DMDFLIALAHEKFKK

EFHC2

616

Q5JST6
IALAHEKFKKNMFEN

EFHC2

621

Q5JST6
KGIKQEAFKDMYDLH

EPYC

226

Q99645
KSKFSQKDLEMLFHG

EXOC2

141

Q96KP1
HLARQFKAIKAKMDE

OLFM1

146

Q99784
KDLPEHAVLKMKGNF

HNRNPU

626

Q00839
NLMDAHKVFQKELGK

MACF1

2826

O94854
IKFHSAAMDEKVIGK

KNL1

1271

Q8NG31
KFLKDKFVEIGAHKD

PLCG2

181

P16885
HMAKAFKEVFGDLLL

PLCG2

416

P16885
MEENNLEHIPKFFKK

OSBPL6

886

Q9BZF3
MDAHKVFQKELGKRT

MACF1

6701

Q9UPN3
HGKPVKNALDLKFDM

PLA2G7

241

Q13093
FFKHQADMLLHGIKV

FAM118A

271

Q9NWS6
KDKFKAERIMVEGFH

SERPINA2

221

P20848
AIHMKKSLEKFVGDA

ATR

2201

Q13535
THFKMLKKLVEEATF

ATR

2241

Q13535
KKAKGQELFDQIMYH

EPB41L5

61

Q9HCM4
QEKMKGDSHKLDFRN

FBRS

101

Q9HAH7
EHNIKKSKMFFKDIE

BRCA2

1021

P51587
VSLFMIHKDGNDFKE

DNAH3

461

Q8TD57
SLMEKHNVLEKGFLK

CCDC91

161

Q7Z6B0
FVEKYEKQIKHFGML

CDC37

151

Q16543
KDHLKKFNELMVTFR

COQ7

91

Q99807
LFKKQIEHDKREMIF

RAP1GDS1

231

P52306
IFHALKMGNFQLVKE

ANKS6

296

Q68DC2
LMNKFVEDTKKGVHQ

CBR1

171

P16152
YKFAKDHAKMGIKEV

DENND1A

431

Q8TEH3
HKAIGFVMVDAKKEA

CASQ2

86

O14958
LMAKDLHFEGMFKKE

EMC3

241

Q9P0I2
KEMKRGKEFHVIFDC

GRIK2

216

Q13002
LFEGMKAFKGKDQQV

BCAT2

101

O15382
NLKKKDGSKHIFEME

CNTROB

86

Q8N137
HKIQEGDFKNMLRLK

LRRN1

276

Q6UXK5
KNIKEKAAHLASMFG

MICAL2

866

O94851
GDIKVEFFHKQNKML

PTEN

251

P60484
MDGKNVKAKLDHVQF

RSBN1L

781

Q6PCB5
QKGFVGCLKDVHFMK

USH2A

1666

O75445
EDRHIKFFDNKTGKM

STRN3

701

Q13033
VDRFNKDIEFMIGHK

SLC6A19

511

Q695T7
KTFMQGEFLKIKHIV

SLFN14

646

P0C7P3
TVKAFKFFQDHKMAL

PTBP2

481

Q9UKA9
HREQGKEQAMFDKKV

SYNM

1516

O15061
KTEKEFMQHARKAGL

MRPL45

51

Q9BRJ2
SKAAFIDHFNVMIKK

SAMD9L

256

Q8IVG5
MKENHEFDGKKLFQH

SLC27A2

531

O14975
KMKKLLFQEAHNGPA

TAOK1

311

Q7L7X3
NFAAEMEKLIKKHQA

TAOK1

506

Q7L7X3
QFDFVKLMDGKQLVK

TENM1

456

Q9UKZ4
QELRKYFKMGDHVKV

SUPT5H

466

O00267
EMRHKLKTAFKNFIE

SUPT16H

771

Q9Y5B9
KPFADEKNILHIMVK

RIPK4

221

P57078
FHVFDKVKVKIMLDS

DIS3

901

Q9Y2L1
DMFKTNLEEFASKHK

SNF8

41

Q96H20
FIDEFNGLHMSKDKR

CDYL2

51

Q8N8U2
PFNKKGSAVFHEIKM

CILP

556

O75339
QKFLKHKFLVQEIMF

NCAPD3

436

P42695
QEKKGAMSHALNFIK

VIL1

306

P09327
KEKFHFKKIIMIGDG

PSPH

166

P78330
MFKHFDKDKSGRLNH

SPTAN1

2331

Q13813
KVFHMLDKDKSGFIE

PVALB

46

P20472
KIEFLKEAHLMSKFN

ROS1

1991

P08922
KNMFEKIHQETFGKS

SF3B3

96

Q15393
GKVKQMQTHFLALKE

UACA

511

Q9BZF9
KPLDVAFMKAIHNKV

SEPTIN2

161

Q15019
LDKMQKENHFLIFVK

SLFN5

86

Q08AF3
DDMKGKDKIVFGNIH

TRIO

2006

O75962
VHFERKADALKAMKQ

ALYREF

151

Q86V81
GIKKVLKKHNDDFEM

MYO5B

1531

Q9ULV0